On Invalid Date, Abeona Therapeutics (NASDAQ: ABEO) reported Q4 2023 earnings per share (EPS) of -$0.64, up 223.08% year over year. Total Abeona Therapeutics earnings for the quarter were -$16.59 million. In the same quarter last year, Abeona Therapeutics's earnings per share (EPS) was $0.52.
As of Q2 2024, Abeona Therapeutics's earnings has grown year over year. Abeona Therapeutics's earnings in the past year totalled -$54.19 million.
What is ABEO's earnings date?
Abeona Therapeutics's earnings date is Invalid Date. Add ABEO to your watchlist to be reminded of ABEO's next earnings announcement.
What was ABEO's revenue last quarter?
On Invalid Date, Abeona Therapeutics (NASDAQ: ABEO) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Abeona Therapeutics's revenue was $68.00 thousand.
What was ABEO's revenue growth in the past year?
As of Q2 2024, Abeona Therapeutics's revenue has grown 147.52% year over year. This is 3.93 percentage points lower than the US Biotechnology industry revenue growth rate of 151.46%. Abeona Therapeutics's revenue in the past year totalled $3.50 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.